ReviewCurrent neuropharmacology2020

A Mechanistic Rationale for PDE-4 Inhibitors to Treat Residual Cognitive Deficits in Acquired Brain Injury.

Rudy Schreiber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.